SCHEMBL21499313

SCHEMBL21499313

COc1cc2c(cc1NC(=O)c1ccc(C(C)(C)C)c(F)c1)CCCCN2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.56
LMNA P02545 3/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
ALDH1A1 P00352 3/20 0.56
DHODH Q02127 2/20 0.56
HPGD P15428 1/20 0.56
HTT P42858 1/20 0.56
KDM4E B2RXH2 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C19 P33261 2/20 0.50
RAB9A P51151 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
NR1H4 Q96RI1 1/20 0.44
ALOX15 P16050 1/20 0.41
PDE4D Q08499 1/20 0.40
ACHE P22303 1/20 0.40
PLAU P00749 1/20 0.40
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21499327 0.87 MAPT (0.53) MAPTLMNASMN1; SMN2ALDH1A1DHODH
SCHEMBL21468465 0.87 DHODH (0.72) MAPTLMNASMN1; SMN2ALDH1A1DHODH
SCHEMBL21468548 0.86 MAPT (0.76) MAPTLMNASMN1; SMN2ALDH1A1DHODH
SCHEMBL21499332 0.85 LMNA (0.58) MAPTLMNASMN1; SMN2ALDH1A1DHODH
SCHEMBL21499356 0.84 MAPT (0.54) MAPTLMNASMN1; SMN2ALDH1A1DHODH
SCHEMBL21499394 0.83 MAPT (0.64) MAPTLMNASMN1; SMN2ALDH1A1DHODH
SCHEMBL21499328 0.83 MAPT (0.61) MAPTLMNASMN1; SMN2ALDH1A1DHODH
SCHEMBL21499382 0.83 MAPT (0.61) MAPTLMNASMN1; SMN2ALDH1A1DHODH
SCHEMBL21499312 0.82 MAPT (0.58) MAPTLMNASMN1; SMN2ALDH1A1DHODH
SCHEMBL21499395 0.82 MAPT (0.62) MAPTLMNASMN1; SMN2ALDH1A1DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450263-B2 Benzo annulenes as antiviral agents SOUTHERN RESEARCH INSTITUTE (US) 2019-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10450263-B2 Benzo annulenes as antiviral agents MAVS, ZC3HAV1, GABBR1 MAPT 760/4885LMNA 3559/4885SMN1; SMN2 804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.